The improvements in non-HDL cholesterol, blood pressure, and inflammatory markers observed in TRIUMPH-4 suggest broad cardiovascular benefits
Despite researchers recording significant weight reduction across subjects, discontinuation rates greater than 50% led to the abandonment of clinical testing before Phase III trials
Whether youre dealing with illness, travel plans, or simply forgot your injection, knowing what happens when you miss a dose and what to do next matters for your weight loss journey
If you have certain health conditions, want to track metabolic improvements beyond weight loss, or have certain health goals, selective lab testing could provide helpful information
Oral Tirzepatide: An oral option for the dual-agonist approach
Batterham, R.L